The class-action suit, filed in federal court in June 2018, centered on a mass mailing to participants in a state-funded HIV assistance program. The contractor for CVS, Fiserv, reportedly mailed letters showing the recipients name, address and a code indicating the person’s enrollment in the assistance program in the clear portion of the envelope.
Some recipients of the letter said CVS violated patient privacy laws and that they could have been harmed if their HIV status became public.
Under the settlement, each recipient of the letter will receive at least $400. People who show they suffered non-financial harm can get as much as $2,500, while people who can show they did suffer financial harm can get up to $10,000. Plantiff’s lawyers may receive up to $1.46 million, a third of the overall reward, according to the Dispatch.
The settlement also prohibits CVS from sending out envelopes that say “HIV” in the future and requires it to train its employees on federal privacy laws.
The settlement was filed in the U.S. District Court Dayton Sept. 10. It still needs approval from a judge.
More articles on pharmacy:
Civica Rx says it isn’t afraid of competition
10 hospitals seeking pharmacy leaders
NIH probes personnel issues at its hospital pharmacy
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.